Bell Potter changed the 12 month price target of DOW from $9.00 to $5.50. This is 24% below the Citi target price.
Goldman Sachs has a hold rating on DOW.
They said that the "stock looks oversold but the risk is that value is eroded by further cost overruns in the PPP contract, an equity injection into Reliance Rail or even a discounted equity placement. UNINVESTABLE AT THE MOMENT."
- Forums
- ASX - By Stock
- citi
DOW
downer edi limited
Add to My Watchlist
0.00%
!
$6.43

Bell Potter changed the 12 month price target of DOW from $9.00...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.43 |
Change
0.000(0.00%) |
Mkt cap ! $4.318B |
Open | High | Low | Value | Volume |
$6.45 | $6.48 | $6.40 | $3.211M | 499.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 8310 | $6.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.44 | 8699 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3160 | 6.310 |
1 | 2403 | 6.240 |
1 | 100 | 6.220 |
1 | 2502 | 6.100 |
1 | 2487 | 6.030 |
Price($) | Vol. | No. |
---|---|---|
6.440 | 720 | 1 |
6.450 | 750 | 1 |
6.460 | 10 | 1 |
6.480 | 1500 | 1 |
6.490 | 7970 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
DOW (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online